AlternativeMed
Ancient Wisdom Natural Remedies Modern Wellness
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Estrogen Receptor-Negative Breast Cancer

Open on HERB 2.0 ↗
2
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00194779
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
Completed · Phase 2
NCT00733408
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Estrogen Receptor-Negative Breast Cancer
🏥 Names
Disease Name
Estrogen Receptor-Negative Breast Cancer
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
🔗 External References
HERB DB
HBDIS027946 ↗
DisGeNET
C4733092
🔍 Raw view — every non-empty column on this row (19 fields)
name
Estrogen Receptor-Negative Breast Cancer
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
umls disease type id
T191
herb disease id
HBDIS027946
disgenet id
C4733092

⚗️ Related Ingredients

1 · shared evidence
Taxol

📋 Clinical Trials

2 · subject of clinical study
NCT00194779 Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With
→ Estrogen Receptor-negative Breast Cancer|Estrogen
NCT00733408 Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastat
→ Estrogen Receptor-negative Breast Cancer|HER2-nega
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables